120 related articles for article (PubMed ID: 24523141)
1. Permeability of the blood-tumor barrier is enhanced by combining vascular endothelial growth factor with papaverine.
Yang ZH; Liu LB; Zhao LN; Liu YH; Xue YX
J Neurosci Res; 2014 Jun; 92(6):703-13. PubMed ID: 24523141
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
3. The modulation of protein kinase A and heat shock protein 70 is involved in the reversible increase of blood-brain tumor barrier permeability induced by papaverine.
Wang ZH; Xue YX; Liu YH
Brain Res Bull; 2010 Nov; 83(6):367-73. PubMed ID: 20728510
[TBL] [Abstract][Full Text] [Related]
4. Effects of combining low frequency ultrasound irradiation with papaverine on the permeability of the blood-tumor barrier.
Wang JE; Liu YH; Liu LB; Xia CY; Zhang Z; Xue YX
J Neurooncol; 2011 Apr; 102(2):213-24. PubMed ID: 20683758
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
Zhang Z; Xia C; Xue Y; Liu Y
J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor increases permeability of the blood-tumor barrier via caveolae-mediated transcellular pathway.
Zhao LN; Yang ZH; Liu YH; Ying HQ; Zhang H; Xue YX
J Mol Neurosci; 2011 Jun; 44(2):122-9. PubMed ID: 21193965
[TBL] [Abstract][Full Text] [Related]
7. Low-dose endothelial monocyte-activating polypeptide-ii increases permeability of blood-tumor barrier by caveolae-mediated transcellular pathway.
Li Z; Liu YH; Xue YX; Liu LB; Wang P
J Mol Neurosci; 2014 Mar; 52(3):313-22. PubMed ID: 24526454
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin.
Xia CY; Zhang Z; Xue YX; Wang P; Liu YH
J Neurooncol; 2009 Aug; 94(1):41-50. PubMed ID: 19234812
[TBL] [Abstract][Full Text] [Related]
10. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.
Xie H; Xue YX; Liu LB; Liu YH
Brain Res; 2010 Mar; 1319():13-20. PubMed ID: 20083091
[TBL] [Abstract][Full Text] [Related]
11. Low-frequency ultrasound irradiation increases blood-tumor barrier permeability by transcellular pathway in a rat glioma model.
Xia CY; Liu YH; Wang P; Xue YX
J Mol Neurosci; 2012 Sep; 48(1):281-90. PubMed ID: 22528460
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway.
Liu LB; Xue YX; Liu YH
J Neurooncol; 2010 Sep; 99(2):187-94. PubMed ID: 20146088
[TBL] [Abstract][Full Text] [Related]
13. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A.
Hofman P; Blaauwgeers HG; Tolentino MJ; Adamis AP; Nunes Cardozo BJ; Vrensen GF; Schlingemann RO
Curr Eye Res; 2000 Aug; 21(2):637-45. PubMed ID: 11148600
[TBL] [Abstract][Full Text] [Related]
14. Effects and mechanism analysis of vascular endothelial growth factor and salvianolic acid B on 125I-low density lipoprotein permeability of the rabbit aortary endothelial cells.
Ba J; Peng H; Chen Y; Gao Y
Cell Biochem Biophys; 2014 Dec; 70(3):1533-8. PubMed ID: 25005771
[TBL] [Abstract][Full Text] [Related]
15. The role of histamine in opening blood-tumor barrier.
Wang Z; Cai XJ; Qin J; Xie FJ; Han N; Lu HY
Oncotarget; 2016 May; 7(21):31299-310. PubMed ID: 27121317
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells.
Deissler HL; Deissler H; Lang GE
Br J Ophthalmol; 2011 Aug; 95(8):1151-6. PubMed ID: 21273213
[TBL] [Abstract][Full Text] [Related]
17. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
[TBL] [Abstract][Full Text] [Related]
18. Role of ATP synthase alpha subunit in low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Xie H; Liu LB
J Neurol Sci; 2011 Jan; 300(1-2):52-8. PubMed ID: 21035144
[TBL] [Abstract][Full Text] [Related]
19. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
[TBL] [Abstract][Full Text] [Related]
20. Additive effect of low-frequency ultrasound and endothelial monocyte-activating polypeptide II on blood-tumor barrier in rats with brain glioma.
Zhang Z; Xue Y; Liu Y; Shang X
Neurosci Lett; 2010 Aug; 481(1):21-5. PubMed ID: 20600613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
